Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:43 PM
Ignite Modification Date: 2025-12-25 @ 4:14 PM
NCT ID: NCT02914457
Description: None
Frequency Threshold: 5
Time Frame: Adverse events were collected from enrollment to study exit. Follow-up time (enrollment to exit) for subjects varied from 1 to 113 days.
Study: NCT02914457
Study Brief: Left Ventricular Synchronous Versus Sequential MultiSpot Pacing for Cardiac Resynchronization Therapy (CRT)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Enrolled Subjects All patients that signed informed consent will be summarized 0 None 3 31 2 31 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Pneumothorax SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (18.1) View
Coronary artery disease SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA (18.1) View
Lead dislogdement SYSTEMATIC_ASSESSMENT General disorders MedDRA (18.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Cardiac vein dissection SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA (18.1) View